Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2008-06-24
2010-12-28
Wen, Sharon (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S388100, C530S388200
Reexamination Certificate
active
07858758
ABSTRACT:
Certain monoclonal antibodies are able to detect urinary trypsin inhibitors (UTIs) that are characteristic of disease in humans. In particular, the UTIs include AMBK, Bikunin, Uristatin, Uristatin-1, Uristatin-2, as defined herein, also including the fragments and aggregates thereof.
REFERENCES:
patent: 6242197 (2001-06-01), Papuashvili
patent: 6583108 (2003-06-01), Tamburini et al.
patent: 6673632 (2004-01-01), Ohshiro
patent: 2001/0055816 (2001-12-01), Rehm et al.
patent: 2002/0004219 (2002-01-01), Corey et al.
patent: 2003/0125577 (2003-07-01), Corey et al.
patent: 2003/0190732 (2003-10-01), Josic
patent: 9-156398 (1997-06-01), None
patent: 2005040222 (2004-07-01), None
Campbell Monoclonal Antibody Technology, 1984, Chapter 1, pp. 1-32.
Fundamental Immunology, William E. Paul, M.D. ed., 3d ed., p. 242, 1993.
Pugia et al.; “Analysis of lingand binding by bioaffinity mass spectrometry” Science Direct (2006) 71-78.
Pugia, et al.; “Immunological evaluation of urinary trypsin inhibitors in blood and urine: Role or N-&O-linked glycoprotiens,” Springer Science & Media, LLC (2006) 24:5-15.
Pugia, et al.; “Bikunin (Urinary Trypsin Inhibitor): Structure, Biological Relevance, and Measurement,” Advances in Clinical Chemistry vol. 44 (2007) pp. 223-245.
Pugia et al.; “Pathophysiology and diagnostic value of urinary trypsin inhibitors,” Clin Chem Lab Med, vol. 43 (1), 2005, pp. 1-16.
Zhu et al.; “Analysis of ligand binding by bioaffinity mass spectrometry,” Clinica Chimica Acta xx, (2006) xxx-xxx, CCA-10235; 8 pages.
Jortani et al.; “Sensitive Noninvasive Marker for the Diagnosis of Probable Bacterial or Viral Infection,” Journal of Clinical Laboratory Analysis, vol. 18 (2004) pp. 289-295.
Pugia et al.; The uristatin dipstick is useful in distinguishing upper respiratory from urinary tract infections,: Clinica Chimica Acta, vol. 341 (2004) pp. 73-81.
Suzuki et al.; “Suppression of Invasion and Peritoneal Carcinomatosis of Ovarian Cancer Cell Line by Overexpression of Bikunin,” Int. J. Cancer, vol. 104, pp. 289-302 (2003).
Capon, et al.; “In acute inflammation, the chondroitin-4 sulphate carried by bikunin is not only longer; it is also undersulphated,” Biochimie, vol. 85 (2003) pp. 101-107.
Kobayashi, et al.; “Supression of urokinase receptor expression by bikunin is associated with inhibition of upstream targets of extracellular signal-regulated kinase-dependent cascade,” Eur. J. Biochem, vol. 269, pp. 3945-3957 (2002).
Mizon, et al.; “Urinary Bikunin Determination Provides Insight into Proteinase/Proteinase Inhibitor Imbalance in Patients with Inflammatory Diseases,” Clin Chem Lab Med 2002, vol. 40(6), pp. 579-586, 2002.
Kreft, et al.; “Polarized Expression of Tamm-Horsfall Protein by Renal Tubular Epithelial Cells Activates Human Granulocytes,” Injection and Immunity, May 2002, pp. 2650-2656.
Suzuki, et al.; “Kunitz-type Protease Inhibitor Bikunin Disrupts Phorbol Ester-induced Oligomerization of CD44 Variant Isoforms Containing Epitope v9 and Subsequently Suppresses Expression of Urokinase-type Plasminogen Activator in Human Chondrosarcoma Cells,” The Journal of Biological Chemistry, vol. 277(10), Mar. 8, 2002, pp. 8022-8032.
Matsumi, et al.; “Changes in Urinary Trypsin Inhibitor in Blood and Urine, as Well as Serum Cytokines in Living Related Liver Transplantation,” Department of Anesthesiology and Resuscitology, Ikayama University Graduate School of Medicine and Dentistry, Okayama 700-8558, Sep. 12, 2002, 12 pages.
Isogai et al.; “Quantitative analysis of bikunin-laden mast cells in follicular eruptions and chronic skin lesions of atopic dermatitis,” Arch Dermatol Res, (2002) vol. 294, pp. 387-392.
Tyagi et al.; “The Liver-Specific Human a,-Microglobulin/Bikunin Precursor (AMBP) is Capable of Self-Association,” Archives of Biochemistry and Biophysics, vol. 399 (1), Mar. 1, 2002, pp. 66-72.
Sugita et al.; “Effect of a human urinary protease inhibitor (Ulinastatin) on respiratory function in pediatric patients undergoing cardiopulmonary bypass,” J. Cardiovasic Surg., vol. 43(4), pp. 437-444, 2002.
Lin et al.; “Plasma and urine levels of urinary trypsin inhibitor in patients with acute and fulminant hepatitis,” Journal of Gastroenterology and Hepatology, vol. 17, pp. 140-147; 2002.
Pugia et al.; “Clinical utility of a rapid test for uristatin,” Clinical Biochemistry, vol. 32, pp. 105-110, 2002.
Moriyama et al.; “Expression of Inter-a Inhibitor Related Proteins in Kidneys and Urine of Hyperoxaluric Rats,” The Journal of Urology, vol. 165,pp. 1687-1692, May 2001.
Takubo et al.; “Urinary trypsin inhibitor levels in the urine of patients with haematological malignancies,” Haematologia, vol. 31(3), pp. 267-272(2001).
Suzuki et al.; “Excretion of Bikunin and Its Fragments in the Urine of Patients with Renal Stones,” The Journal of Urology, vol. 166, pp. 268-274, Jul. 2001.
Janssen et al.; “Expression of inter-a-trypsin inhibitor and tumor necrosis factor-stimulated gene 6 in renal proximal tubular epithelial cells,” Kidney International, vol. 60, pp. 126-136, 2001.
Mizon et al.; “The chondroitin sulfate chain of bikunin-containing proteins in the inter-a-inhibitor family increases in size in inflammatory diseases,” Eur. J. Biochem, vol. 268, pp. 2217-2724, 2001.
Suzuki et al.; “Structure and function analysis of urinary trypsin inhibitor (UTI): identification of binding domains and signaling property of UTI by analysis of truncated proteins,” Biochimica et Biophysica Acta, pp. 26-36, 2001.
Kobayashi et al.; “Identity of Urinary Trypsin Inhibitor-binding Protein to Link Protein,” The Journal of Biological Chemistry, vol. 275 (28), pp. 21185-21191, Jul. 14, 2000.
Thuveson et al.; “The Low pH in Trans-Golgi Triggers Autocatalytic Cleavage of Pre-a-inhibitor Heavy Chain Precursor,” The Journal of Biological Chemistry, vol. 275 (40), pp. 30996-3 1000, Oct. 6, 2000.
Mizon et at.; “Human pre-a-inhibitor is a positive acute-phase protein that is more susceptible than inter-a-inhibitor to proteolysis by stimulated neutrophils,” European Journal of Clinical Investigation, vol. 30, pp. 79-86, 2000.
Dean et al.; “Effects of inter-a-inhibitor and several of its derivatives on calcium oxalate crystallization in vitro,” Clinical Science, vol. 98, pp. 471-480, 2000.
Balduyck et al.; “Inflammation-induced'systemic proteolysis of inter-a-inhibitor in plasma from patients with sepsis,” J. Lab Clin Med, vol. 135 (2), pp. 188-198, Feb. 2000.
Fries et at.; “Bikunin—not just a plasma proteinase inhibitor,” The International Journal of Biochemistry & Cell Biology, vol. 32, pp. 125-137, 2000.
Iida et al.; “Expression of Bikunin mRNA in Renal Epithelial Cells After Oxalate Exposure,” The Journal of Urology, vol. 162, pp. 1480-1486, Oct. 1999.
Marengo et at.; “Differential Expression of Urinary Inter-a-Trypsin Inhibitor Trimers and Dimers in Normal Compared to Active Calcium Oxatate Stone Forming Men,” The Journal of Urology, vol. 159, pp. 1444-1450, May 1998.
Bost et at.; “Intera-a-trypsin inhibitor proteoglycan family, A group of proteins binding and stabilizing the extracellular matrix,” Eur. J. Biochem, vol. 252, pp. 339-346, 1998.
Dawson et al.; “Inter-a-inhibitor in calcium stones,” Clinical Science, vol. 95, pp. 187-193, 1998.
Mizon et at.; “Human pre-a-inhibitor: isolation from a by-product of industrial scale plasma fractionation and structural analysis of its H3 heavy chain,” Journal of Chromatography B, vol. 692, pp. 281-291, 1997.
Marlor et al,; “Identification and Cloning of Human Placental Bikunin, a Novel Serine Protease Inhibitor Containing Two Kunitz Domains,” The Journal of Biologi
Anderson-Mauser Linda
Gleason Shannon
Murphy Solomon H.
Pugia Michael J.
Sommer Ronald G.
Pollack Noam R.
Siemens Healthcare Diagnostics Inc.
Wen Sharon
LandOfFree
Monoclonal antibodies for detection of urinary trypsin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies for detection of urinary trypsin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies for detection of urinary trypsin... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4207871